11&bgr;-Hydroxysteroid Dehydrogenase Type 1 Inhibitors as Promising Therapeutic Drugs for Diabetes: Status and Development

By  

Current Medicinal Chemistry, Vol. 17, Iss. 5, 2010-02 ,pp. : 412-422

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of 17&bgr;-Hydroxysteroid Dehydrogenase Type 1

By  

Current Medicinal Chemistry, Vol. 15, Iss. 2, 2008-01 ,pp. : 137-150

Bentham Science Publishers

Access to resources Recommend Favorite

11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes

By Morgan Stuart A   Tomlinson Jeremy W  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 9, 2010-09 ,pp. : 1067-1076

Informa Healthcare

Access to resources Recommend Favorite

11β-Hydroxysteroid dehydrogenase Type 1 as a novel therapeutic target in metabolic and neurodegenerative disease

By Walker Brian R   Seckl Jonathan R  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 6, 2003-12 ,pp. : 771-783

Informa Healthcare

Access to resources Recommend Favorite

11β-Hydroxysteroid dehydrogenase-1 as a therapeutic target for metabolic diseases

By Fotsch Christopher   Askew Ben C   Chen Jian Jeffrey  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 3, 2005-03 ,pp. : 289-303

Informa Healthcare

Access to resources Recommend Favorite